66 customized services results for

ProBio and DAAN have agreed to strengthen their cooperation in the cell and gene therapy(CGT) and biologics

editing technologyLentivirus gene knockout technologyFLIPRTetraEnVison & PHERAStarTop countLiquid

different AAV transfer plasmidsProprietary PowerS™-ITRrs StrainAAV is known to be the most common vector in gene

and VEGFR would activate luciferase reporter gene expression.

It is a milestone on the path to industrialization of the cell and gene therapy industry, pioneered by

efficiency and longer protein expression time, and also avoids the genetic risk of introducing foreign genes

AAV vector is the most widely used vehicle in delivering gene of interest (GOI) in in vivo gene therapies.ProBio

We will be able to meet the rapidly evolving demands of gene, cell, antibody and protein therapies.

clinical trial and commercial manufacturing, contributing to the development of high quality cell and gene

The demand for viral vectors is rapidly increasing due to the recent growth of the gene therapy market